Mr BSG

Mannkind: Overlooked Biotech With Excellent Prospects (Part VI)

" Therefore, the failure of these other three products in the marketplace is totally irrelevant."

" why has Mannkind’s stock fallen to $2.89? That’s down a whopping 87% from its March 2006 price of $22! "


The only thing that's irrelvant is your senseless pumping of this stock. You contradict yourself throughout the 6 Part Pump, to the point of being totally laughable.

MNKD, PFE, NOVO and Lilly are all inhaled and all have or will (MNKD) FAIL.

PFE has the largest Pharma Salesforce in the world and they couldn't convince Dr.s or patients to use exubera.

MNKD has no salesforce

MNKD has no partner and will never find a partner to kick in $1 Billion.

MNKD has an inferior product that has already been rejected by the market.

MNKD will NEVER get FDA Approval.

MNKD will be out of cash by Nov. 2008

MNKD has 600 employees that do exactly WHAT all day!

I stick by my prediction of $1.00 by Dec 2008 and bankrupt in 2009. In fact, both may come sooner than expected.

Buyer beware of this dog, regardless of what you read on the internet.